SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001437749-22-028255
Filing Date
2022-12-01
Accepted
2022-12-01 09:26:02
Documents
6

Document Format Files

Seq Description Document Type Size
1 dffn20221130_prer14a.htm PRER14A 543320
2 dffn20221117_prec14aimg001.jpg GRAPHIC 7826
3 dffn20221117_prec14aimg002.jpg GRAPHIC 7339
4 dffn20221117_prec14aimg003.jpg GRAPHIC 7339
5 pc01.jpg GRAPHIC 777445
6 pc02.jpg GRAPHIC 548897
  Complete submission text file 0001437749-22-028255.txt   2402758
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-37942 | Film No.: 221437586
SIC: 2834 Pharmaceutical Preparations